INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NuScale Power Corporation

Pomerantz LLP is investigating potential securities-fraud claims involving NuScale after UBS downgraded the SMR developer to Sell and cut its price target to $6 from $10. UBS cited eroding first-mover advantage, a roughly five-year construction timeline, limited firm customer commitments, stalled Romania and TVA initiatives, and an estimated $700 million of negative free cash flow over 2026-2028. NuScale shares fell $1.60, or 15.67%, to $8.61 on September 11.

Analysis

The legal investigation is not independently informative on liability or damages; the investable issue is whether SMR can finance a multi-year commercialization gap without diluting equity. If cash burn approaches the cited trajectory, capital raises would likely be priced against a weakened project pipeline, creating a reflexive cycle of dilution, customer hesitation, and higher required returns on project financing. The key near-term variable is therefore cash runway and contracted backlog quality, not litigation headlines.

Competitive positioning may bifurcate the advanced-nuclear complex rather than impair it broadly. BWXT benefits if utilities and governments shift preference toward established nuclear supply-chain execution, while OKLO and NNE can retain speculative upside where their designs have clearer customer or strategic partnerships; neither is a clean fundamental substitute, so valuation discipline remains essential. Utilities such as CEG are likely largely insulated because their earnings are driven by existing generation fleets and power-price contracts, not SMR deployment schedules.

Over the next 1-3 months, the risk is further multiple compression if management cannot convert announcements into binding, financeable commitments or gives no credible funding plan. Over 6-18 months, a Romanian project milestone, TVA-related definitive agreement, federal financing support, or a strategic equity investment could sharply reverse a crowded short, irrespective of current cash-flow economics. The contrarian view is that the selloff may already discount substantial execution failure; a litigation press release alone should not be treated as a fresh fundamental catalyst.

Key Decisions for Investors

• Maintain a bearish bias on SMR, but do not short solely on the legal headline. Initiate only after confirming borrow availability and a failed rebound below the post-downgrade gap area; use a 1-3 month horizon and size for headline-driven short-squeeze risk.
• Prefer a relative-value expression: short SMR / long BWXT in approximately beta-neutral dollars for 3-6 months. The thesis is a rotation from long-duration, externally financed reactor developers toward an established nuclear-services and component supplier; exit if SMR discloses a fully funded, binding commercial project or BWXT misses nuclear backlog conversion.
• For existing SMR longs, treat the next earnings release and any cash-runway disclosure as the decision point. Reduce exposure if guidance implies materially higher financing needs or backlog remains non-binding; retain only a small event position if there is verifiable strategic funding rather than preliminary partnership language.
• Set alerts for definitive customer contracts with deposits, government-backed financing terms, Romania construction authorization, and TVA contractual commitments. Any of these would falsify the near-term financing-stress thesis more meaningfully than a change in analyst ratings or litigation developments.